弘前大学大学院医学研究科　呼吸器内科学講座

研究業績

2019年度研究業績

2018年度研究業績

2017年度研究業績

2016年度以前

2017年研究業績

1. Tanaka H, Taima K, Tanaka Y, Itoga M, Ishioka Y, Morimoto T, Nakagawa H, Baba K, Hasegawa Y, Takanashi S, Tasaka S. A phase I study of afatinib for patients aged 75 or older with advanced non-small cell lung cancer harboring EGFR mutations. Med Oncol 35: 34, 2018. doi: 10.1007/s12032-018-1098-3.
2. Asami T, Ishii M, Namkoong H, Yagi K, Tasaka S, Asakura T, Suzuki S, Kamo T, Okamori S, Kamata H, Zhang H, Hegab AE, Hasegawa N, Betsuyaku T. Anti-inflammatory roles of mesenchymal stromal cells during acute Streptococcus pneumoniae pulmonary infection in mice. Cytotherapy (in press) doi: 10.1016/j.jcyt.2018.01.003.
3. Tanaka H, Taima K, Morimoto T, Tanaka Y, Itoga M, Nakamura K, Hayashi A, Kumagai M, Yasugahira H, Mikuniya M, Okudera K, Takanashi S, Tasaka S. A single-arm phase II study of nab-paclitaxel for patients with chemorefractory non-small cell lung cancer. BMC Cancer 17: 683, 2017. doi: 10.1186/s12885-017-3684-8.
4. Namkoong H, Ishii M, Mori T, Sugiura H, Tasaka S, Sakurai M, Koda Y, Kato J, Hasegawa N, Okamoto S, Betsuyaku T. Clinical and radiological characteristics of patients with late-onset severe restrictive lung defect after hematopoietic stem cell transplantation. BMC Pulm Med 17: 123, 2017. doi: 10.1186/s12890-017-0466-7.
5. Yagi K, Ishii M, Namkoong H, Asami T, Iketani O, Asakura T, Suzuki S, Sugiura H, Yamada Y, Nishimura T, Fujiwara H, Funatsu Y, Uwamino Y, Kamo T, Tasaka S, Betsuyaku T, Hasegawa N. The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases. BMC Infect Dis 17: 558, 2017. doi: 10.1186/s12879-017-2665-5.
6. Tasaka S, Tatsumi K on behalf of the Assembly of Pulmonary Circulation and Lung Injury, the Japanese Respiratory Society. Clinical practice of acute respiratory distress syndrome in Japan: A nationwide survey and scientific evidences. Respir Investig 55: 257-263, 2017.
7. Akashiba T, Ishikawa Y, Ishihara H, Imanaka H, Ohi M, Ochiai R, Kasai T, Kimura K, Kondoh Y, Sakurai S, Shime N, Suzukawa M, Takegami M, Takeda S, Tasaka S, Taniguchi H, Chohnabayashi N, Chin K, Tsuboi T, Tomii K, Narui K, Hasegawa N, Hasegawa R, Ujike Y, Kubo K, Hasegawa Y, Momomura SI, Yamada Y, Yoshida M, Takekawa Y, Tachikawa R, Hamada S, Murase K. The Japanese Respiratory Society Noninvasive Positive Pressure Ventilation (NPPV) Guidelines (second revised edition). Respir Investig 55: 83-92, 2017. doi: 10.1016/j.resinv.2015.11.007.
8. Yamamoto A, Saito N, Ogasawara S, Shiratori T, Kondo J, Itoga M, Kayaba H. Intracellular Storage of Duffy Antigen-Binding Chemokines by Duffy-Positive Red Blood Cells. Clin. Lab. 2017 Apr 1;63(4):717-723.
9. Saito N, Itoga M, Kimura M, Inoue F, Minakawa S, Kimura T, Ozaki H, Saito Y, Takahashi M, Fujishima T, Mizuno S, Ogawa S, Kitayama Y, Kudo K, Minami K, Abo F, Takano Y, Ohdaira N, Hamada S, Ueki S, Hirokawa M, Kayaba H. Evaluating effectiveness of infection control efforts in hospitals using information in microbiological laboratory databases. J Gen Fam Med. 2017 Jun 15; 18(6): 354-359.
10. Tanaka Y, Taima K, Tanaka H, Itoga M, Ishioka Y, Shiratori T, Tsuchiya J, Sakamoto H, Takanashi S, Tasaka S. Emergency radiotherapy for spinal cord compression due to bone sarcoidosis. Intern Med. 2017 Nov 20. doi: 10.2169/internalmedicine.9299-17.
11. Taima K, Tanaka H, Tanaka Y, Itoga M, Takanashi S, Tasaka S. Regression of crizotinib-associated complex cystic lesions after switching to alectinib. Intern Med. 56: 2321-2324, 2017.
12. 田坂定智．ARDSの病態と疾患フェノタイプ．呼吸器内科 33: 1-8, 2018.
13. 田坂定智．重症肺炎とその治療．最新医学 別冊 診断と治療のABC 129 呼吸器感染症．p.112-122, 最新医学社, 大阪, 2017.
14. 田坂定智．ニューモシスチス肺炎．日本呼吸器学会びまん性肺疾患学術部会 厚生労働省難治性疾患政策研究事業びまん性肺疾患に関する調査研究班 編．気管支肺胞洗浄（BAL）法の手引き 改訂第3版．p.157-160, 克誠堂出版, 東京, 2017.
15. 糸賀正道，田坂定智．市中肺炎に対するステロイド療法および非抗菌薬療法の意義．呼吸器内科 31: 133-139, 2017.
16. 田坂定智．急性呼吸窮迫症候群（ARDS）．呼吸器内科 31: 32-38, 2017.
17. 田坂定智．急性呼吸窮迫症候群の病態・治療の最前線．日内会誌 106: 114-119, 2017.